Sonic Healthcare Limited (AU:SHL)
ASX:SHL
Want to see AU:SHL full AI Analyst Report?
SHL Stock Chart & Stats
AU$20.56
-AU$0.19(-0.67%)
At close: 4:00 PM EST
AU$20.56
-AU$0.19(-0.67%)
Day’s Range― - ―
52-Week RangeAU$18.88 - AU$29.24
Previous CloseN/A
Volume607.50K
Average Volume (3M)1.62M
Market Cap
AU$10.05B
Enterprise ValueAU$17.39B
Total Cash (Recent Filing)AU$557.12M
Total Debt (Recent Filing)AU$7.34B
Price to Earnings (P/E)10.6
Beta0.74
Next Earnings
Aug 26, 2026EPS Estimate
0.66Next Dividend Ex-DateN/A
Dividend Yield4.69%
Share Statistics
EPS (TTM)0.50
Shares Outstanding494,237,950
10 Day Avg. Volume1,694,025
30 Day Avg. Volume1,619,425
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)1.55
Price to Sales (P/S)1.34
P/FCF Ratio13.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$24.71Price Target Upside20.20% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
EPS Forecast (FY)1.22
Revenue Forecast (FY)AU$10.95B
Bulls Say, Bears Say
Bulls Say
Strong Free Cash Flow GenerationSonic's FCF growth (+16.6%) and high OCF-to-net-income conversion indicate durable cash conversion from operations. This supports ongoing capex, a progressive dividend policy, sale-and-leaseback funding and potential buybacks, preserving long-term capital allocation flexibility.
Consistent Organic Growth Across MarketsSustained ~5% organic growth across diversified geographies shows resilient demand for diagnostics. Contract wins and regional outperformance reduce reliance on any single market, supporting stable revenue streams and long-run volume-driven operating leverage.
Margin Expansion And Integration BenefitsModest margin improvement and targeted integration (LADR, digital pathology adoption) demonstrate effective cost and synergy capture. Automation, new hub labs and platform migration create structural efficiency gains that can sustain modest margin improvement over the medium term.
Bears Say
Higher Leverage From Acquisitions And Property SpendIncreased leverage from acquisitions and property investments raises interest and refinancing sensitivity. Management targets investment-grade cover but higher net debt and elevated interest guidance reduce financial flexibility for opportunistic M&A or aggressive capital returns if cash flow weakens.
U.S. Margin Pressure And RestructuringWeak U.S. performance and ongoing anatomical pathology rationalisation are structural mix and margin risks. Lower organic growth and restructuring costs can depress U.S. profitability for multiple quarters, limiting group margin improvement and requiring execution to restore prior margins.
Working-capital Disruption From Change Healthcare IncidentBilling/collection disruption elevated receivables and temporarily increased net debt and working-capital needs. Delayed collection benefits and deferred revenue-collection gains into FY2027 create persistent cash-conversion risk and tighter liquidity over the next several quarters.
Sonic Healthcare Limited News
SHL FAQ
What was Sonic Healthcare Limited’s price range in the past 12 months?
Sonic Healthcare Limited lowest share price was AU$18.88 and its highest was AU$29.24 in the past 12 months.
What is Sonic Healthcare Limited’s market cap?
Sonic Healthcare Limited’s market cap is AU$10.05B.
When is Sonic Healthcare Limited’s upcoming earnings report date?
Sonic Healthcare Limited’s upcoming earnings report date is Aug 26, 2026 which is in 121 days.
How were Sonic Healthcare Limited’s earnings last quarter?
Sonic Healthcare Limited released its earnings results on Feb 18, 2026. The company reported AU$0.5 earnings per share for the quarter, missing the consensus estimate of AU$0.527 by -AU$0.027.
Is Sonic Healthcare Limited overvalued?
According to Wall Street analysts Sonic Healthcare Limited’s price is currently Undervalued.
Does Sonic Healthcare Limited pay dividends?
Sonic Healthcare Limited pays a Semiannually dividend of AU$0.63 which represents an annual dividend yield of 4.69%. See more information on Sonic Healthcare Limited dividends here
What is Sonic Healthcare Limited’s EPS estimate?
Sonic Healthcare Limited’s EPS estimate is 0.66.
How many shares outstanding does Sonic Healthcare Limited have?
Sonic Healthcare Limited has 494,237,950 shares outstanding.
What happened to Sonic Healthcare Limited’s price movement after its last earnings report?
Sonic Healthcare Limited reported an EPS of AU$0.5 in its last earnings report, missing expectations of AU$0.527. Following the earnings report the stock price went up 9.887%.
Which hedge fund is a major shareholder of Sonic Healthcare Limited?
Currently, no hedge funds are holding shares in AU:SHL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sonic Healthcare Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$24.71 (20.20% Upside)
AU$24.71 (20.20% Upside)
Blogger Sentiment
Bullish
AU:SHL Sentiment 100%
Sector Average 72%
Sector Average 72%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-16.99%
12-Months-Change
Fundamentals
Return on Equity
6.39%
Trailing 12-Months
Asset Growth
10.74%
Trailing 12-Months
Company Description
Sonic Healthcare Limited
Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It also offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, after-hours general practice services, general practice IT solutions, and community-based healthcare services. The company operates in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, Belgium, and internationally. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.
SHL Stock 12 Month Forecast
Average Price Target
AU$24.71
▲(20.20% Upside)
Technical Analysis
Healius Limited
―
Genetic Signatures Ltd.
―
Integral Diagnostics Ltd.
―
Australian Clinical Labs Ltd
―
Monash IVF Group Ltd
―
Options Prices
Currently, No data available
---